A new approach to anti-inflammatory drugs.
A new approach to anti-inflammatory drugs.
复制标题
抗炎药物的新方法。
DOI:
10.1016/0006-2952(79)90651-8
复制
发表时间:
1979
影响因子:
5.8
通讯作者:
J. Vane
中科院分区:
文献类型:
--
作者:
G. Higgs;R. Flower;J. Vane
All aspirin-like drugs so far tested inhibit prostaglandin biosynthesis but do not prevent the generation of the hydroxy acid 12-l-hydroxyeicosatetraenoic acid (HETE) by arachidonate lipoxygenase. HETE is chemotactic for polymorphonuclear leukocytes, and the failure to inhibit lipoxygenase may explain why the aspirin-like drugs have little or no effect on leukocyte migration at doses which are both anti-inflammatory and inhibit prostaglandin synthesisin vivo. 3-Amino-1-[m-(trifluoromethyl)-phenyl]-2-pyrazoline (BW755C) inhibits both pathways of arachidonic acid metabolismin vitroand causes a dose-dependent reduction in carrageenin-induced oedema in the rat paw. BW755C also reduces prostaglandin concentration in inflammatory exudates and has a significantly greater effect on leukocyte migration than indomethacin. The dual inhibition of arachidonate cyclo-oxygenase (prostaglandin synthetase) and lipoxygenase could lead, therefore, to increased anti-inflammatory activity.